Answers are grounded in this paper and cite their sources.
This article critically examines the existing literature on taxation of excess or supernormal profits of large multinationals and calculates excess profits in India with special reference to the pharmaceutical sector. It concludes with policy recommendations on taxing excess profits using an allowance of capital employed approach.
No takes yet. Share an insight, caveat, or question.
Sehra et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: